Baird Financial Group, Inc. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$214,188
+106461.2%
1,554
+0.3%
0.00%0.0%
Q4 2022$201
-99.9%
1,550
-54.2%
0.00%0.0%
Q3 2022$374,000
+14.4%
3,381
-22.6%
0.00%0.0%
Q2 2022$327,000
-31.6%
4,366
-28.6%
0.00%0.0%
Q1 2022$478,000
-26.7%
6,119
-15.5%
0.00%
-50.0%
Q4 2021$652,000
-5.0%
7,238
-2.5%
0.00%0.0%
Q3 2021$686,000
+52.8%
7,421
+28.4%
0.00%
+100.0%
Q2 2021$449,000
+16.6%
5,781
+11.9%
0.00%0.0%
Q1 2021$385,000
-48.2%
5,166
+18.5%
0.00%
-50.0%
Q4 2020$743,000
+11.7%
4,360
-7.9%
0.00%0.0%
Q3 2020$665,000
-7.5%
4,735
+5.6%
0.00%
-33.3%
Q2 2020$719,000
+44.4%
4,482
-12.0%
0.00%
+50.0%
Q1 2020$498,000
-15.2%
5,095
+12.0%
0.00%0.0%
Q4 2019$587,000
+145.6%
4,549
+43.2%
0.00%
+100.0%
Q3 2019$239,000
-2.0%
3,176
+98.5%
0.00%0.0%
Q2 2019$244,000
+9.4%
1,600
-46.8%
0.00%
-50.0%
Q1 2018$223,000
-53.8%
3,005
-65.4%
0.00%
-33.3%
Q4 2017$483,000
+7.8%
8,688
-11.9%
0.00%0.0%
Q3 2017$448,000
+49.8%
9,867
+11.3%
0.00%
+50.0%
Q2 2017$299,000
+34.1%
8,869
+17.5%
0.00%0.0%
Q1 2017$223,0007,5500.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders